100 Episodo

  1. Key Factors for Choosing the Right CDMO

    Publicado: 28/8/2023
  2. Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry

    Publicado: 21/8/2023
  3. Unsuccessful Regulatory Filings for Biosimilar Approval: A Comprehensive Review

    Publicado: 15/8/2023
  4. Drug Patent Reports now available on Amazon

    Publicado: 14/8/2023
  5. Artificial Intelligence and Machine Learning in Drug Discovery and Development

    Publicado: 10/8/2023
  6. Prevalence and timing of authorized generics in the US market

    Publicado: 8/8/2023
  7. Insights into Shifting Dynamics: Orange Book and Biologic PTAB Trends

    Publicado: 7/8/2023
  8. The Evolution of Reverse Payment Cases: Courts and Agencies’ Approaches in Pharma Litigation

    Publicado: 5/8/2023
  9. Understanding the Impact of Authorized Generics on Drug Pricing: The Entacapone Case Study

    Publicado: 2/8/2023
  10. Review of 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020: A Focus on Intellectual Property and Regulatory Considerations

    Publicado: 28/7/2023
  11. DrugPatentWatch reveals NIH funding for patents

    Publicado: 27/7/2023
  12. Filing Strategies for Maximizing Pharma Patents

    Publicado: 25/7/2023
  13. DrugChatter Featured Questions

    Publicado: 8/6/2023
  14. DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights

    Publicado: 22/5/2023
  15. NPR and DrugPatentWatch – Can drug injector pens be swapped?

    Publicado: 16/5/2023
  16. Utilizing 505(b)(2) Regulatory Pathway for New Drug Applications: An Overview on the Advanced Formulation Approach and Challenges

    Publicado: 19/4/2023
  17. Social Return on Investment

    Publicado: 6/9/2022
  18. CDCDB: A large and continuously updated drug combination database

    Publicado: 7/6/2022
  19. DrugPatentWatch named “Best of the Web” by Genetic Engineering News

    Publicado: 2/5/2022
  20. The value of method of use patent claims in protecting your therapeutic assets

    Publicado: 5/4/2022

3 / 5

DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management

Visit the podcast's native language site